← Genetic Insights

SLC7A14

SLC7A14 is a gene that carries instructions for a transporter protein inside the retina's light-sensing cells. When both copies of this gene carry harmful changes, it can cause autosomal recessive retinitis pigmentosa. The link between SLC7A14 and this form of inherited retinal disease is established, though it is a relatively uncommon cause. A smaller body of research also connects this gene to a form of hearing difficulty alongside vision loss in some people. As of the date of this review, no treatment targeting this gene has been approved, and research remains largely at the laboratory and animal stage.

Disease Category
autosomal recessive

Where things stand · Treatment

Treatment & research

No approved therapy currently targets SLC7A14, and the research that exists is mostly aimed at understanding how the gene works.

Where things stand · Clinical trials

Studies that may be relevant to review

No clinical trials specific to SLC7A14 were identified in the reviewed records.

Check current clinical trials for this gene — the Finder pulls live studies from ClinicalTrials.gov.

Find clinical trialsOpens the Clinical Trials Finder with this gene — you can change or remove it.

What this gene means

The SLC7A14 gene provides the recipe for a protein that moves certain amino acids, the building blocks of proteins, across cell membranes.

The SLC7A14 gene provides the recipe for a protein that moves certain amino acids, the building blocks of proteins, across cell membranes. Laboratory work indicates the protein sits in lysosomes, the small recycling compartments inside cells, where it specifically transports the amino acid arginine. In the eye, the gene is active in the layer of the retina, the sheet of cells that converts light into signals the brain can read. In mice, its activity rises as the retina develops and continues in the mature retina, suggesting it has an ongoing role in keeping photoreceptors healthy. This condition follows an pattern, which means a person generally needs a harmful change in both copies of the gene — one inherited from each parent — before vision problems appear.

How it may affect vision

Variants (mutations) in SLC7A14 are linked to autosomal recessive retinitis pigmentosa.

Variants (mutations) in SLC7A14 are linked to retinitis pigmentosa. Retinitis pigmentosa typically begins with difficulty seeing in dim light and a gradual narrowing of the peripheral field of vision, though the exact course varies from person to person. Researchers have reported that the appearance of SLC7A14-related disease can differ between individuals. In one report, the same gene change was linked to retinitis pigmentosa in one family and, in a separate case, linked to Leber Congenital Amaurosis (LCA), a more severe, early-onset retinal condition. Because these observations come from a small number of families, they cannot predict how any one person's vision will change.

What is known

SLC7A14 was first linked to autosomal recessive retinitis pigmentosa through exome sequencing and screening of 248 unrelated patients, in which changes in the…

SLC7A14 was first linked to retinitis pigmentosa through exome sequencing and screening of 248 unrelated patients, in which changes in the gene accounted for about 2% of cases in that group. That study also showed the gene is specifically active in the layer, and that reducing its activity in zebrafish and removing it entirely in mice led to abnormal eyes and retinal degeneration. Follow-up work in zebrafish confirmed that the gene is essential for normal eye development and visual behavior. And, loss of SLC7A14 can cause small eyes, loss of rod photoreceptors, and cell death in the retina. A 2022 study in mice and humans found that loss of the protein disrupts the cell's recycling and nutrient-sensing machinery, leading to progressive loss of photoreceptors and of the inner hair cells of the inner ear. Laboratory characterization has since confirmed that the protein works as a lysosomal arginine transporter. It is also well documented that the frequency of SLC7A14 changes varies by population. In a Japanese cohort of 146 patients, no clearly disease-causing variants were found, suggesting these changes may be rare in some groups.

What is uncertain

Much of the detailed biology of SLC7A14 still comes from animals and cultured cells rather than from large groups of patients.

Much of the detailed biology of SLC7A14 still comes from animals and cultured cells rather than from large groups of patients. Since only a handful of affected families have been described in detail, researchers still need to map-out severity, age of onset, and rate of progression in humans. It is not yet clear why the same SLC7A14-variant produced retinitis pigmentosa in one person and the more severe LCA in another. Some studies have found only a single harmful copy of the gene in patients, versus the two copies the recessive pattern. Yhe significance of those single findings are still unresolved. How consistently hearing is affected, and how closely it tracks with vision loss, remains an open question that needs more human study.

Treatment & research

No approved therapy currently targets SLC7A14, and the research that exists is mostly aimed at understanding how the gene works.

No approved therapy currently targets SLC7A14, and the research that exists is mostly aimed at understanding how the gene works. Scientists have created stem cell lines from a patient with an SLC7A14 change and from his parents, giving researchers a human-cell tool to study the disease in the laboratory. Recent laboratory work identified the diabetes drug metformin as a substance that can block the transporter in a test tube, which researchers describe only as a starting point for studying the protein, not as a treatment. Animal and cell findings like these are important for understanding the disease, but they are not treatments available to patients.

  • The first report linking SLC7A14 to retinitis pigmentosa

    Human genetic screening combined with zebrafish and mouse laboratory experiments.
    What was found:
    Harmful SLC7A14 changes were found in about 2% of these patients, the gene was active specifically in photoreceptors, and removing it caused retinal degeneration in animals.
    Why it matters:
    This established SLC7A14 as a genuine cause of inherited retinal degeneration and showed the protein is important for retinal health.

    Limitation: The functional evidence came from animals, and the human cases were a small fraction of the group studied.

  • Confirming the protein as a lysosomal arginine transporter

    Laboratory biochemical study using purified protein.
    What was found:
    The protein specifically carries the amino acid arginine into lysosomes, and metformin was found to inhibit it in the test tube.
    Why it matters:
    Understanding exactly what the protein does is a foundation for any future attempt to develop targeted therapies.

    Limitation: This is basic molecular research, not a treatment, and metformin's effect was only observed in a test tube.

  • Combined hearing and vision loss from lysosomal dysfunction

    Mechanistic study in mice and humans.
    What was found:
    The protein normally sits in lysosomes of inner-ear hair cells and photoreceptors, and its loss disrupted cell recycling, causing progressive loss of both hearing and vision cells.
    Why it matters:
    It suggests SLC7A14 disease can involve the ear as well as the eye, which is relevant for monitoring.

    Limitation: The number of people with hearing involvement described was small, so how common this is remains uncertain.

  • Different diagnoses from SLC7A14 changes

    Human genetic study of a small number of affected families.
    What was found:
    They identified changes causing retinitis pigmentosa in one family and Leber congenital amaurosis, a more severe early-onset condition, in a separate case.
    Why it matters:
    It shows the same gene can be linked to retinal conditions of differing severity.

    Limitation: Very few patients carried these changes, so broader patterns cannot be drawn.

  • How often SLC7A14 changes appear varies by population

    Human genetic screening of a defined cohort.
    What was found:
    No clearly disease-causing changes were found; detected variants were unlikely to be the cause of disease in this group.
    Why it matters:
    It indicates that the frequency of SLC7A14-related disease can differ substantially between ethnic groups.

    Limitation: A negative result in one population does not rule out the gene's importance elsewhere.

For family & caregivers

Unlike many retinitis pigmentosa genes, SLC7A14 has been linked in some research to hearing difficulty alongside vision loss, so families may wish to be alert…

Unlike many retinitis pigmentosa genes, SLC7A14 has been linked in some research to hearing difficulty alongside vision loss, so families may wish to be alert to signs of hearing changes and discuss hearing checks with a clinician. Because the condition is , parents of an affected child are typically unaffected carriers. Siblings may wish to consider genetic counseling to understand their own carrier status.

Questions to ask your clinician

Questions to bring to a retinal specialist or genetic counselor…

  • Does my genetic report show changes in both copies of SLC7A14, or only one, and what does that mean for the diagnosis?
  • Given the reported link to hearing changes, would a hearing evaluation be appropriate for me or my children?
  • What pattern of vision change is most consistent with my current retinal findings?
  • Would additional family members benefit from genetic counseling because this condition is inherited in a recessive pattern?
  • Are there monitoring tests you would recommend over time to track the retina?
  • How might my specific gene changes affect eligibility for future research studies?

What you can do next

Confirming a genetic result with a retinal specialist and a genetic counselor can help put the finding in context for you and your family.

Confirming a genetic result with a retinal specialist and a genetic counselor can help put the finding in context for you and your family. Because SLC7A14 has been linked to hearing changes in some reports, a hearing evaluation may be a useful topic to raise with your care team. If a single gene variant was reported rather than two, it may be worth discussing whether additional genetic testing is warranted, since a second change can sometimes be missed. RP Hope's genetic testing resources explain what testing involves and what questions to bring to a counselor.

Support, accessibility and family guidance(the same for every gene)

This guidance applies to anyone living with an inherited retinal condition, whichever gene is involved. Anything specific to this gene is in the section above.

Ask before helping
People differ widely in what assistance they want, and it changes by task and by day. Asking first respects that, and avoids help that gets in the way.
Low-vision rehabilitation
Low-vision specialists work on practical skills and tools for the sight someone has — lighting, contrast, magnification, orientation and mobility.
Accessible technology
Screen readers, magnification, high-contrast modes and voice control are built into phones and computers. Small settings changes often help sooner than new equipment.
School and work
Accommodations are often available well before vision loss is severe. Starting the conversation early usually makes it easier.
Emotional and community support
A genetic result affects the whole family. Connecting with others living with RP helps people feel less alone with it.
Genetic counselling
A genetic counsellor can explain what a result means for relatives, and what testing options exist, without anyone being pushed into a decision.
Last reviewed: November 9, 2026Reviewer: Carin Elam

Medical disclaimer: This page is for education and navigation only — not medical advice, diagnosis, or treatment. These summaries are paraphrases of published research; always confirm details with a qualified clinician and primary sources.